Client News

SEATTLE–(BUSINESS WIRE)–Audere, a digital health nonprofit developing solutions to improve global health, announced its partnership with Medical Diagnostech, a developer and manufacturer of lateral flow rapid diagnostic test kits. The partnership will pair Medical Diagnostech’s MD SARS-nCoV-2 Antigen Device1, the first test manufactured in Africa to receive South African Health Products Regulatory Authority (SAHPRA) approval late last year, with Audere’s HealthPulse digital companion app.

December 15, 2021 (London): LumiraDx (Nasdaq: LMDX) today announced a partnership with digital health non-profit Audere, to offer a self-collected COVID-19 nasal specimen collection kit that has been authorized for use with the LumiraDx SARS-CoV-2 RNA STAR Complete assay to process self-collected samples. Audere’s testing solution, HealthPulse@home, closely aligns with LumiraDx’s continual efforts to increase testing access and support a growing number of testing needs.

US-based digital health non-profit organization, Audere has collaborated with diagnostic test kits manufacturer Medical Diagnostech (MD) to launch Covid-19 Antigen Test coupled with a digital companion app.
The agreement will combine Medical Diagnostech’s SARS-nCoV-2 Antigen test with Audere’s HealthPulse digital companion app.

The world of music licensing is about to change dramatically, thanks to some groundbreaking developments in the AI space. Now, APM Music — owned by Sony Music Publishing and Universal Music Publishing Group — has inked a major licensing partnership with AI-focused music upstart XdMind.